Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,676 | 213 | 98.8% |
| Education | $58.62 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,055 | 50 | $0 (2024) |
| Amgen Inc. | $681.27 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $398.74 | 18 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $343.62 | 19 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $323.92 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $260.61 | 8 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $211.56 | 11 | $0 (2023) |
| Relypsa, Inc. | $208.30 | 20 | $0 (2019) |
| Vifor Pharma, Inc. | $167.29 | 7 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $131.55 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,421 | 58 | AstraZeneca Pharmaceuticals LP ($258.31) |
| 2023 | $1,138 | 45 | AstraZeneca Pharmaceuticals LP ($234.07) |
| 2022 | $384.08 | 21 | AstraZeneca Pharmaceuticals LP ($117.12) |
| 2021 | $658.88 | 31 | AstraZeneca Pharmaceuticals LP ($185.71) |
| 2020 | $376.66 | 21 | AstraZeneca Pharmaceuticals LP ($260.26) |
| 2019 | $460.12 | 27 | Janssen Pharmaceuticals, Inc ($223.66) |
| 2018 | $163.98 | 6 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($70.83) |
| 2017 | $131.14 | 7 | Fresenius USA Marketing, Inc. ($40.34) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEPHROLOGY | ||||||
| 12/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $35.21 | General |
| 12/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Inflammation | ||||||
| 11/16/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: Hyperkalemia | ||||||
| 11/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 09/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Hyperkalemia | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Immunology | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: DIABETES | ||||||
| 08/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Nephrology | ||||||
| 08/16/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.87 | General |
| Category: NEPHROLOGY | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 648 | 1,370 | $525,936 | $177,821 |
| 2022 | 11 | 723 | 1,656 | $581,715 | $189,859 |
| 2021 | 14 | 802 | 2,048 | $673,749 | $255,424 |
| 2020 | 13 | 880 | 2,511 | $689,151 | $260,176 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 35 | 169 | $133,510 | $54,539 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 327 | $97,446 | $23,468 | 24.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 45 | 122 | $76,372 | $23,153 | 30.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 104 | 210 | $55,020 | $21,996 | 40.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 211 | $36,714 | $15,002 | 40.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 76 | $29,032 | $11,413 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 122 | $50,752 | $9,642 | 19.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 15 | 36 | $23,760 | $9,586 | 40.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 47 | 74 | $11,692 | $4,601 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $11,638 | $4,422 | 38.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 47 | 188 | $152,920 | $60,456 | 39.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 149 | 430 | $68,455 | $27,641 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 333 | $100,665 | $22,663 | 22.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 117 | $75,474 | $22,225 | 29.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 185 | $42,114 | $16,844 | 40.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 81 | 83 | $36,556 | $14,363 | 39.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 40 | $27,060 | $10,975 | 40.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 74 | 144 | $23,220 | $9,247 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 105 | $44,639 | $3,041 | 6.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,820 | $1,665 | 28.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 16 | $4,792 | $740.10 | 15.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 40 | 227 | $181,980 | $73,032 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 364 | $110,216 | $40,418 | 36.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 173 | 608 | $95,435 | $38,701 | 40.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 61 | 150 | $95,000 | $28,468 | 30.0% |
About Dr. Warren Chang, MD
Dr. Warren Chang, MD is a Nephrology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083674550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Chang, MD has received a total of $4,734 in payments from pharmaceutical and medical device companies, with $1,421 received in 2024. These payments were reported across 216 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,676).
As a Medicare-enrolled provider, Chang has provided services to 3,053 Medicare beneficiaries, totaling 7,585 services with total Medicare billing of $883,281. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Daly City, CA
- Active Since 03/27/2006
- Last Updated 08/26/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083674550
Products in Payments
- LOKELMA (Drug) $548.94
- JYNARQUE (Drug) $530.29
- FARXIGA (Drug) $506.53
- Veltassa (Drug) $375.59
- Velphoro (Drug) $322.62
- ACTHAR (Biological) $294.83
- Parsabiv (Drug) $226.81
- Kerendia (Drug) $211.56
- INVOKANA (Drug) $208.07
- Aranesp (Biological) $149.47
- TARPEYO (Drug) $129.91
- KRYSTEXXA (Biological) $129.25
- Parsabiv (Biological) $118.47
- JARDIANCE (Drug) $113.74
- Ozempic (Drug) $100.59
- Fabhalta (Drug) $97.25
- LifeVest (Device) $70.83
- EPOGEN (Biological) $59.86
- RAYALDEE (Drug) $58.62
- XARELTO (Drug) $52.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Daly City
Dr. Christian Cruz, Md, MD
Nephrology — Payments: $64,624
Dr. Robert Tseng, Md, MD
Nephrology — Payments: $18,913
Dr. Hector Santiesteban, Medical Doctor, MEDICAL DOCTOR
Nephrology — Payments: $3,483
Lauren Macaraeg, M.d, M.D
Nephrology — Payments: $2,347
Dr. Albert Kao, Md, MD
Nephrology — Payments: $2,024
Dr. Philip Hertz, Md, MD
Nephrology